Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether on course (6 cycles) of consolidation
therapy with Revlimid can shrink or slow the growth of Chronic Lymphocytic Leukemia (CLL) in
the bone marrow.